![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Direxion Daily Energy Bull 2X Shares ETF
ERX
Invesco DB Commodity Index Tracking Fund
DBC
Energy Select Sector SPDR Fund
XLE
4
Direxion Daily Financial Bull 3X Shares ETF
FAS
5
VanEck Agribusiness ETF
MOO
US Stock MarketDetailed Quotes
Plus Therapeutics (PSTV)
- 3.600
- -0.030-0.83%
Trading Jul 30 11:28 ET
24.78MMarket Cap-2.07P/E (TTM)
3.690High3.571Low21.48KVolume3.690Open3.630Prev Close77.56KTurnover0.33%Turnover RatioLossP/E (Static)6.88MShares23.42552wk High2.07P/B23.25MFloat Cap2.90052wk Low--Dividend TTM6.46MShs Float187687.462Historical High--Div Yield TTM3.28%Range %2.900Historical Low3.610Avg Price1Lot Size
PSTV Stock Chart
Real-Time
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
PSTV Orderflow
Unit: --
PSTV Orderflow Trend
IntradayDayWeekMonth
No Data
Plus Therapeutics (PSTV) News
Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference
Express News | Plus Therapeutics - to Change Name to Cerenome, and Ticker to Cnsy on August 3, 2026
Plus Therapeutics Secures Regional Coverage Agreement With Medical Mutual for CNSide Cerebrospinal Fluid Assay for Metastatic CNS Cancer
Express News | Plus Therapeutics Secures Regional Coverage Agreement With Medical Mutual for Cnside® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
Plus Therapeutics and Genomic Testing Cooperative Announce Collaboration to Expand CNSide CSF Assay With Next-Generation Sequencing Profiling
Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide CSF Assay Platform
Plus Therapeutics (PSTV) Stock Forum
$Plus Therapeutics (PSTV.US)$ Reuters
1m
Plus Therapeutics Secures Regional Coverage Agreement With Medical Mutual for Cnside® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
1m
Plus Therapeutics Secures Regional Coverage Agreement With Medical Mutual for Cnside® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
1
$Plus Therapeutics (PSTV.US)$
Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide® CSF Assay Platform
by Globe Newswire
Follow
HOUSTON and LAKE FOREST, Calif., July 16, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company") and Genomic Testing Cooperative, LCA ("GTC") today announced a collaboration to integrate GTC’s next-generation sequencing (NGS) technology into the CNSide® cerebrospinal fl...
Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide® CSF Assay Platform
by Globe Newswire
Follow
HOUSTON and LAKE FOREST, Calif., July 16, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company") and Genomic Testing Cooperative, LCA ("GTC") today announced a collaboration to integrate GTC’s next-generation sequencing (NGS) technology into the CNSide® cerebrospinal fl...
1
$Plus Therapeutics (PSTV.US)$ lost too much might as well hold forever.
1
1
$Plus Therapeutics (PSTV.US)$ CURSED FOR EVER 😂
$Plus Therapeutics (PSTV.US)$ will turn to green end of today!!
1
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)